Comparative study of available medical therapy for hypercalcemia of malignancy
- 31 March 1983
- journal article
- clinical trial
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 74 (3), 421-432
- https://doi.org/10.1016/0002-9343(83)90961-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effects of Dichloromethylene Diphosphonate on Serum and Urinary Calcium in Primary HyperparathyroidismAnnals of Internal Medicine, 1981
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.JCI Insight, 1980
- Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple MyelomaNew England Journal of Medicine, 1980
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Metabolic Effects of Diphosphonate in Primary HyperparathyroidismThe Journal of Clinical Pharmacology, 1977
- Nonautonomy of parathyroid hormone and urinary cyclic AMP in primary hyperparathyroidismThe American Journal of Surgery, 1977
- Acute Hyperphosphatemia and Acute Persistent Renal Insufficiency Induced by Oral Phosphate TherapyAnnals of Internal Medicine, 1975
- Drugs for Disorders of BoneDrugs, 1974
- The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatitein vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised ratsCalcified Tissue International, 1970